Larry Wood Biography and Net Worth

Mr. Wood has served as our President and Chief Executive Officer since September 2025 and a member of our board of directors since April 2024. He previously served as Corporate Vice President, Transcatheter Aortic Valve Replacement from February 2007 to September 2025, and as Group President for Surgical Structural Heart from 2023 to September 2025, at Edwards Lifesciences, a global leader in patient-focused medical innovations for structural heart disease and critical care and surgical monitoring. Mr. Wood has more than 35 years of experience in the medical technology industry at both Edwards Lifesciences and Baxter Healthcare Corporation in positions including manufacturing management, regulatory affairs and strategic and clinical marketing, primarily for the surgical heart valve therapy business. Mr. Wood received an M.B.A. from Pepperdine Graziadio Business School.

What is Larry L. Wood's net worth?: The estimated net worth of Larry L. Wood is at least $510.86 thousand as of August 7th, 2026. Wood owns 23,900 shares of PROCEPT BioRobotics stock worth more than $510,863 as of August 10th. This net worth estimate does not reflect any other assets that Wood may own. Learn More about Larry L. Wood's net worth.
How do I contact Larry L. Wood?: The corporate mailing address for Wood and other PROCEPT BioRobotics executives is 900 ISLAND DRIVE, REDWOOD CITY CA, 94065. PROCEPT BioRobotics can also be reached via phone at 650-232-7200 and via email at [email protected]. Learn More on Larry L. Wood's contact information.
Has Larry L. Wood been buying or selling shares of PROCEPT BioRobotics?: Within the last three months, Larry L. Wood has bought $498,315.00 in shares of PROCEPT BioRobotics stock. Most recently, on Friday, August 7th, Larry L. Wood bought 23,900 shares of PROCEPT BioRobotics stock. The stock was acquired at an average cost of $20.85 per share, with a total value of $498,315.00. Following the completion of the transaction, the chief executive officer now directly owns 23,900 shares of the company's stock, valued at $498,315. Learn More on Larry L. Wood's trading history.
Who are PROCEPT BioRobotics' active insiders?: PROCEPT BioRobotics' insider roster includes Antal Desai (Director), Frederic Moll (Director), Alaleh Nouri (EVP), Hisham Shiblaq (EVP, Chief Commercial Officer), Kevin Waters (EVP, CFO), Larry Wood (CEO), and Reza Zadno (CEO). Learn More on PROCEPT BioRobotics' active insiders.
Are insiders buying or selling shares of PROCEPT BioRobotics?: In the last twelve months, PROCEPT BioRobotics insiders bought shares 4 times. They purchased a total of 450,162 shares worth more than $10,981,406.16. In the last twelve months, insiders at the sold shares 9 times. They sold a total of 24,229 shares worth more than $601,946.03. The most recent insider tranaction occured on August, 7th when CEO Larry L Wood bought 23,900 shares worth more than $498,315.00. Insiders at PROCEPT BioRobotics own 4.0% of the company. Learn More about insider trades at PROCEPT BioRobotics.
Information on this page was last updated on 8/7/2026.

Larry L. Wood Insider Trading History at PROCEPT BioRobotics

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
8/7/2026	Buy	23,900	$20.85	$498,315.00	23,900

Larry L. Wood Buying and Selling Activity at PROCEPT BioRobotics

PROCEPT BioRobotics Company Overview

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.

Today's Range

Now: $21.47

$20.83

$21.79

50 Day Range

MA: $21.59

$16.69

$29.09

2 Week Range

Now: $21.47

$16.67

$42.71

Volume

601,604 shs

Average Volume

1,613,056 shs

Market Capitalization

$1.22 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.89